Skip to main content
. 2012 Sep;8(3):163–170.

Table 4.

Illustrates the salivary Cp ferroxidase activities (U/ml) and specific activities in control and patients groups

Groups Cp Ferroxidase activity (U/ml) Cp Ferroxidase specific activity (U/mg)

  Control 0.212 0.040
  Patients marsh IIIa a0.0958 a0.0159
  Patients marsh IIIb a0.097 a0.0172
  Patients marsh IIIc a0.1667 a0.0267
  Patients marsh 0, I a0.1687 a0.0298
a

Significant difference in comparison to control at P<0.05.